Key result
Antipsychotic drug target gene expression shows no association with VTE risk.
Why the study?
Past observational studies reporting on the association between antipsychotics and venous thromboembolism remain controversial, and underlying mechanisms are not fully understood.
Do antipsychotic drugs increase the risk of venous thromboembolism?
Observational (n=218,792)
Do antipsychotic drugs increase the risk of venous thromboembolism?
While adverse event databases suggest an association between antipsychotic drugs and VTE, Mendelian randomization fails to provide genetic evidence for a causal relationship.
Answers are grounded in this paper and cite their sources.
MR finds no causal link to VTE; challenges adverse event signals but leaves open confounding and needs confirmation.
AIMS: Past observational studies have reported on the association between antipsychotic drugs and venous thromboembolism (VTE); however, the conclusions remain controversial, and its mechanisms are yet to be fully understood. Thus, in this study, we aim to determine the associations of antipsychotic drugs with VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE), and their potential mechanisms. METHODS: We first mined the adverse event signals of VTE, DVT, and PE caused by antipsychotic drugs in Food and Drug Administration Adverse Event Reporting System (FAERS). Next, we used two-sample Mendelian randomization (MR) method to investigate the association of antipsychotic drug target gene expression with VTE, DVT, and PE, using single-nucleotide polymorphisms as genetic instruments. We not only used the expression of all antipsychotic drug target genes as exposure to perform MR analyses but also analyzed the effect of single target gene expression on the outcomes. RESULTS: In the FAERS, 1694 cases of VTE events were reported by 16 drugs. However, using the MR approach, no significant association was determined between the expression of all antipsychotic target genes and VTE, DVT, or PE, either in blood or brain tissue. Although the analysis of single gene expression data showed that the expression of nine genes was associated with VTE events, these targets lacked significant pharmacological action. CONCLUSIONS: Adverse event mining results have supported the claim that antipsychotic drugs can increase the risk of VTE. However, we failed to find any genetic evidence for this causal association and potential mechanisms. Thus, vigilance is still needed for antipsychotic drug-related VTE despite the limited supporting evidence.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) conducted an observational in Venous thromboembolism (n=218,792). Antipsychotic drug target gene expression vs. Unexposed/reference group was evaluated on Venous thromboembolism (VTE) (OR 1.03, 95% CI 0.99-1.07, p=0.143). Mendelian randomization analysis found no significant association between the overall expression of antipsychotic drug target genes in blood and the risk of venous thromboembolism.
Synapse has enriched 10 related papers. Consider them for comparative context: